Get yourself updated on key emerging technology markets

Know about our market intelligence coverage in key sectors

Product is added to your Wishlist

GLOBAL NEWBORN SCREENING MARKET: ANALYSIS & FORECASTS, 2016-2023

The purpose of the study is to gain a holistic view of global Newborn Screening market in terms of various factors influencing it like recent trends, technological advancements, and regulatory aspects of automation systems.

SKU: BH014A
Published Year: 2017
 
 

Advancement of next generation sequencing, high throughput screening (HTS), and cell free fetal DNA are factors supporting the growth of newborn screening market. There has been a rise in the overall demand of the newly developed newborn screening tests due to increasing metabolic, endocrine, genetic and haemoglobin disorders. At present the main focus of the government initiatives is towards developing non-invasive solutions, launching large number of newborn screening programs, controlling the increasing level of genetic disorders, and integrating advanced technologies to fulfil the unmet needs of the patients.
 
The purpose of the study is to gain a holistic view of global Newborn Screening market in terms of various factors influencing it like recent trends, technological advancements, and regulatory aspects of automation systems. In addition, the study also comprises of exhaustive information on the product shortcomings, unmet needs, perception on the new products, preferences, competitive landscape, restraints and opportunities and the other vital information with respect to Newborn Screening products. The scope of this report is centered upon conducting a detailed study of the solutions allied with Newborn Screening market. The market has been segmented into ‘Product’, ‘Technology’, ‘Condition’ and ‘region’. Moreover, global Newborn Screening market report deliberates in detail, the analysis of all the macro & micro factors. It also evaluate the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders. All of the above mentioned report coverage parameters are discussed across different regions like The Americas, Europe, Asia Pacific (APAC), and Rest of the World (ROW).

Report coverage of the Newborn Screening market includes key elements considered for the detailed analysis of the market:
• Market Overview provides an in depth analysis of the global Newborn Screening market scenario, economic outlook, technology trends, and legal Requirements & Regulations
• Market Dynamics: Drivers, Challenges and Opportunities related to the global Newborn Screening market
• Competitive Insights provides a comprehensive understanding of the business environment of the market, growth matrix, market share analysis, company value chain analysis, and CCI index among others
• An in-depth analysis of the different product divisions across various countries consists of valuable insights into the trend followed in the market

The answers to the following key questions can be found in the report:

• What are the major market drivers, challenges and opportunities of the newborn screening market and their use cases?
•What are the key trends and developments in the newborn screening market for genetic disease management?
•What are the key developmental strategies in different applications across all regions?
•What are different types of newborn screening methods and the latest technologies entering the market?
•How will the key market players leverage on key developments such as Mergers and Acquisitions, Partnerships, and Product Launches among others?
•Which geographical region will lead the global newborn screening market by the end of the forecast period?
•Who are the key players in the newborn screening market?
•What are the key government regulations for different newborn screening solutions?
•What are the key market trends and key developments in different geographical regions?
•What are the genetic disorders detectable by different these screening tests?
•What are the appropriate technologies for the detection of aneuploidies, micro-deletions, duplications, copy number variations and translocations? 
•What is the global and regional market for newborn screening tests, through 2023?
•How many genetic conditions are detected during newborn genetic screening in the U.S., U.K., Germany and other countries?
•What is the status of newborn genetic screening in developed, developing and other countries? 

The report includes the profiles of major players in the newborn screening market that allows the readers to gain an insight into the various industry trends.

 

TABLE OF CONTENT
Executive Summary
1 Research Scope and Methodology
1.1 Report Scope
1.2 Research Methodology
1.3 Market Segmentation
1.4 Assumptions
1.5 Data and Prediction Modelling
2 Market Overview
2.1 Global Newborn Screening Market Overview (Addressable Market Size and Growth Potential), 2012-2016
2.2 Recent Historical Trends, 2013-2016
2.3 Global Newborn Screening Market, 2016
2.3.1 Key Market Development and Strategies
2.3.1.1 Mergers and Acquisition
2.3.1.2 Product Launch & Developments
2.3.1.3 Partnerships, Collaborations & Joint Ventures
2.3.1.4 Business Expansions and Contracts
2.3.2 Market Share Concentration
2.4 Technology Trends in Newborn Screening Market
2.5 Legal Requirements and Regulations
2.5.1 Regulatory Bodies
2.5.2 Consortia and Associations
2.6 Patent Analysis
3 Market Dynamics
3.1 Drivers
3.2 Challenges
3.3 Opportunities
4 Major Demand Determinants
4.1 Overview
4.2 Global Metabolic Disorders Statistics, 2016
4.2.1 Organic acid
4.2.1.1 Propionic acidemia (PROP)
4.2.1.2 Methylmalonic acidemia (methylmalonyl-CoA mutase, MUT)
4.2.1.3 Methylmalonic acidemia (cobalamin disorders; Cbl A, B)
4.2.1.4 Isovaleric academia (IVA)
4.2.1.5 Glutaric acidemia type I (GA1)
4.2.1.6 Others
4.2.2 Fatty Acid Oxidation
4.2.2.1 Carnitine uptake defect/carnitine transport defect (CUD)
4.2.2.2 Medium-chain acyl-CoA dehydrogenase deficiency (MCAD)
4.2.2.3 Very long-chain acyl-CoA dehydrogenase deficiency (VLCAD)
4.2.2.4 Others
4.2.3 Amino acid
4.2.3.1 Argininosuccinic aciduria (ASA)
4.2.3.2 Citrullinemia, type I (CIT)
4.2.3.3 Maple syrup urine disease (MSUD)
4.2.3.4 Homocystinuria (HCY)
4.2.3.5 Others
4.3 Global Endocrine Disorders Statistics, 2016
4.4 Global Haemoglobin Disorders Statistics, 2016
4.5 Other Disorders Statistics, 2016
5 Global Newborn Screening Market Pricing Trends, 2013-2016
5.1 Overview
5.2 Metabolic Tests
5.3 Endocrine Tests
5.4 Haemoglobin Tests
5.5 Hearing Screen Test
5.6 Critical Congenital Heart Diseases (CCHD) Test
5.7 Others
6 Competitive Insights
6.1 Market Share Analysis, 2015 & 2016
6.2 Growth Share Matrix
6.2.1 By Test
6.2.2 By Country
6.2.3 By Technology
6.3 Comprehensive Competitive Index
6.4 Competitor Value Chain Analysis
6.5 Competitor Supply Chain Analysis
6.6 Competitor Brand-Value Matrix
6.7 Porter’s Five Force Analysis
8 Global Newborn Screening Market by Technology, 2016-2023 ($Million)
8.1 Overview
8.2 Tandem Mass Spectrometry
8.3 Electrophoresis
8.4 Enzymes and Immunoassays
8.5 DNA-based Assays
8.6 Pulse Oximetry Technology
8.7 Others
9 Global Newborn Screening Market by Condition, 2016-2023 ($Million)
9.1 Overview
9.2 Metabolic Disorders
9.2.1 Organic acid
9.2.1.1  Propionic acidemia (PROP)
9.2.1.2 Methylmalonic acidemia (methylmalonyl-CoA mutase, MUT)
9.2.1.3 Methylmalonic acidemia (cobalamin disorders; Cbl A, B)
9.2.1.4 Isovaleric academia (IVA)
9.2.1.5 Glutaric acidemia type I (GA1)
9.2.1.6 Others
9.2.2 Fatty Acid Oxidation
9.2.2.1 Carnitine uptake defect/carnitine transport defect (CUD)
9.2.2.2 Medium-chain acyl-CoA dehydrogenase deficiency (MCAD)
9.2.2.3 Very long-chain acyl-CoA dehydrogenase deficiency (VLCAD)
9.2.2.4 Others
9.2.3 Amino acid
9.2.3.1 Argininosuccinic aciduria (ASA)
9.2.3.2 Citrullinemia, type I (CIT)
9.2.3.3 Maple syrup urine disease (MSUD)
9.2.3.4 Homocystinuria (HCY)
9.2.3.5 Others
9.3 Endocrine disorders
9.3.1 Congenital hypothyroidism (CH)
9.3.2 Congenital adrenal hyperplasia (CAH)
9.4 Hemoglobin disorders
9.4.1 S,S disease (Sickle cell anemia) (Hb SS)
9.4.2 S, ßeta-thalassemia (Hb S/ßTh)
9.4.3 S,C disease (Hb S/C)
9.5 Other disorders
9.5.1 Biotinidase deficiency (BIOT)
9.5.2 Cystic fibrosis (CF)
9.5.3 Others
10 Global Newborn Screening Market by Product, 2016-2023 ($Million)
10.1 Overview
10.2 Instruments
10.3 Reagents
10.4 Other Consumables and Accessories
11 Global Newborn Screening Market by Region, 2016-2023 ($Million)
11.1 Overview
11.2 North America
11.2.1. U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe (RoE)
11.4 Asia Pacific (APAC)
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia Pacific (RoAPAC)
11.5 Rest of the World (RoW)
12 End-User Perception About Newborn Screening
12.1 Key Factors Influencing Decision About Newborn Screening Market
12.2 Influence of GPs, Labs, and KoLs on Decision Making
12.3 Innovation Trends of Newborn Screening Tests
12.4 Level of Competition among players
12.5 Willingness to Purchase Newborn Screening Tests/Kits
12.6 Perception About Pricing
12.7 Technology Preferences
12.8 Perception about Brand
12.9 Selection Criteria for Newborn Screening Tests
12.1 Sources of Information about Newborn Screening
12.11 Information Required to Purchase a new product
12.12 Any Unmet needs or Shortcoming with Market Available Newborn Screening Products
12.13 Preferred Channel for Purchasing
13 Company Profiles
13.1 PerkinElmer, Inc.
13.1.1 Company Overview
13.1.2 Product Profile
13.1.3 Financials
13.1.3.1  Financial Summary
13.1.4 Recent Developments & Strategies
13.1.5 SWOT Analysis
13.2 AB Sciex LLC (A Subsidiary of Danaher Corporation)
13.3 Drager
13.4 Waters Corporation
13.5 Smith’s Group
13.6 Fisher & Paykel Healthcare
13.7 Natus Medical Incorporated
13.8 Masimo Corporation
13.9 Agilent Technologies Inc.
13.10 Bio-Rad Laboratories, Inc.
13.11 Covidien PLC
13.12 GE Healthcare (A Subsidiary of General Electric Company)
13.13 Trivitron Healthcare
13.14 Snapshot of Other Key Players

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields

OUR HAPPY CLIENTS


related reports

 

OUR CLIENTS